Clinical Trial: Individualized Contrast Dosing Strategy for Prevention of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention A Multicenter, Prospective, Randomized, Open-Label, Endpoint-Blinded Trial (AIDE-PCI Trial) (China)

China, Sept. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Individualized Contrast Dosing Strategy for Prevention of Contrast-Associated Acute Kidney Injury After Percutaneous Coronary Intervention A Multicenter, Prospective, Randomized, Open-Label, Endpoint-Blinded Trial (AIDE-PCI Trial)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131338

Registration Time: 2026/09/01

Type: Interventional study

Primary Sponsor: Dongguan Xiegang Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341129

Published by HT Digital Content Services with permission from Health Daily Digest....